Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • After-school exercise program enhances cognition in 7-, 8- and 9-year-olds

  • Rising prevalence of sleep apnea in U.S. threatens public health

  • New clues revealed to understand brain stimulation

  • Selectively rewiring brain's circuitry to treat depression

  • New learning mechanism for individual nerve cells

  • Rising prevalence of sleep apnea in US threatens public health

  • Sleep twitches light up the brain

  • The dangers of teens using marijuana

  • Talk therapy -- not medication -- best for social anxiety disorder, large study finds

  • Signature of aging in brain: Researchers suggest that the brain's 'immunological age' is what counts

  •